Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 2 |
2005 | 1 |
2019 | 1 |
2020 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer.
Cancers (Basel). 2020 Sep 25;12(10):2763. doi: 10.3390/cancers12102763.
Cancers (Basel). 2020.
PMID: 32992844
Free PMC article.
Magnetic Resonance-guided Stereotactic Radiotherapy for Localized Prostate Cancer: Final Results on Patient-reported Outcomes of a Prospective Phase 2 Study.
Tetar SU, Bruynzeel AME, Oei SS, Senan S, Fraikin T, Slotman BJ, Moorselaar RJAV, Lagerwaard FJ.
Tetar SU, et al. Among authors: oei ss.
Eur Urol Oncol. 2021 Aug;4(4):628-634. doi: 10.1016/j.euo.2020.05.007. Epub 2020 Jun 12.
Eur Urol Oncol. 2021.
PMID: 32536573
Clinical Trial.
Item in Clipboard
A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results.
Bruynzeel AME, Tetar SU, Oei SS, Senan S, Haasbeek CJA, Spoelstra FOB, Piet AHM, Meijnen P, Bakker van der Jagt MAB, Fraikin T, Slotman BJ, van Moorselaar RJA, Lagerwaard FJ.
Bruynzeel AME, et al. Among authors: oei ss.
Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):1086-1094. doi: 10.1016/j.ijrobp.2019.08.007. Epub 2019 Aug 13.
Int J Radiat Oncol Biol Phys. 2019.
PMID: 31419510
Clinical Trial.
Item in Clipboard
Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy.
Senan S, Burgers S, Samson MJ, van Klaveren RJ, Oei SS, van Sörnsen de Koste J, Voet PW, Lagerwaard FJ, Maarten van Haarst J, Aerts JG, van Meerbeeck JP.
Senan S, et al.
Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):999-1006. doi: 10.1016/s0360-3016(02)03028-6.
Int J Radiat Oncol Biol Phys. 2002.
PMID: 12419425
Clinical Trial.
Item in Clipboard
Use of CD-ROM-based tool for analyzing contouring variations in involved-field radiotherapy for Stage III NSCLC.
van Sörnsen de Koste JR, Senan S, Underberg RW, Oei SS, Elshove D, Slotman BJ, Lagerwaard FJ.
van Sörnsen de Koste JR, et al.
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):334-9. doi: 10.1016/j.ijrobp.2005.02.016.
Int J Radiat Oncol Biol Phys. 2005.
PMID: 16168828
Item in Clipboard
Can errors in reconstructing pre-chemotherapy target volumes contribute to the inferiority of sequential chemoradiation in stage III non-small cell lung cancer (NSCLC)?
Lagerwaard FJ, van de Vaart PJ, Voet PW, Nijssen-Visser MR, Schuchhard-Schipper RH, Joosten HP, Oei SS, Senan S.
Lagerwaard FJ, et al.
Lung Cancer. 2002 Dec;38(3):297-301. doi: 10.1016/s0169-5002(02)00225-8.
Lung Cancer. 2002.
PMID: 12445752
Item in Clipboard
Cite
Cite